| Literature DB >> 28101192 |
Junxia Wang1, Yanning Li1, Mingzhi Xu1, Dandan Li2, Yu Wang1, Jinsheng Qi2, Kunyu He2.
Abstract
Insufficient matrix metalloproteinase (MMP)-9 and MMP-2 is considered to be a contributor of extracellular matrix (ECM) accumulation in diabetic nephropathy (DN). C-peptide can reverse fibrosis, thus exerting a beneficial effect on DN. Whether C-peptide induces MMP-9 and MMP-2 to reverse ECM accumulation is not clear. In the present study, in order to determine ECM metabolism, rat mesangial cells were treated with high glucose (HG) and C-peptide intervention, then the early and late effects of C-peptide on HG-affected MMP-9 and MMP-2 were evaluated. Firstly, it was confirmed that HG mainly suppressed MMP-9 expression levels. Furthermore, C-peptide treatment induced MMP-9 expression at 6 h and suppressed it at 24 h, revealing the early dual effects of C-peptide on MMP-9 expression. Subsequently, significant increase in MMP-9 expression at 72, 96 and 120 h C-peptide treatment was observed. These changes in MMP-9 protein content confirmed its expression changes following late C-peptide treatment. Furthermore, at 96 and 120 h C-peptide treatment reversed the HG-inhibited MMP-9 secretion, further indicating the late induction effect of C-peptide on MMP-9. The present results demonstrated that C-peptide exerted a late induction effect on MMP-9 in HG-stimulated rat mesangial cells, which may be associated with the underlying mechanism of C-peptide's reversal effects on DN.Entities:
Keywords: C-peptide; diabetic nephropathy; extracellular matrix; matrix metalloproteinase-2; matrix metalloproteinase-9
Year: 2016 PMID: 28101192 PMCID: PMC5228027 DOI: 10.3892/etm.2016.3873
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447